KRAS and cancer: The KRAS gene mutation results in the appearance of oncogenic properties that are causally involved in the development of several types of cancers (13), including pancreatic carcinomas, liver cancer, colorectal cancer, lung carcinomas, biliary tract carcinomas, bladder cancer, endometrial cancer, cervical cancer, breast cancer, and myeloid leukemia (14-16).